TRIAD PHARMACEUTICALS ADOPTS NEW NAME OF ARISAPH PHARMACEUTICALS

Triad Pharmaceuticals, Inc., a privately held drug discovery and design biopharmaceutical company, announced today that the Company is changing its name to Arisaph Pharmaceuticals, effective immediately. The Arisaph name establishes the Company's unique identity. Moreover, Arisaph is derived from the ancient Greek language and reflects the Company's goal of creating best-in-class or smart medicines to improve human heath.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/11-14-2005/0004215072&EDATE=)